SBWire

Glo Comms USA is a leading recruiter in the tech sector. An experienced and well established name with deep insight into the way this burgeoning market has evolved, the firm has built networks and established connections across the industry that enable it to support clients and candidates looking to thrive in this exciting environment.

Dr. Franziska Huettner (a well-known Manhattan, New York mommy makeover plastic surgery specialist) and Director of the Plastic Surgery Group of NYC announced today that she is now offering non-surgical vaginal rejuvenation / vaginal tightening with ThermiVA©.

Remote clinical operations present an innovative opportunity for the evolution of life sciences into a more versatile, digital age. During the pandemic, Trans Perfect in partnership with Innovaderm used Trial Interactive tech to make a significant contribution to partner organizations seeking to find new treatments to COVID-19 and to help support further research. Trial Interactive is a connected eClinical experience that is designed to make improvements in a number of key areas, including compliance, speed and quality across site detection, selection and activation. Remote clinical trials were achieved by giving customers access to Trial Interactive's Study Document Collaboration solution by integrating tailored remote monitoring rooms. Now, Trans Perfect and Innovaderm are looking to scale the deployment of Trial Interactive to offer the opportunity of remote clinical operations on a much broader basis. The two companies have been in a long-standing collaboration that began with language translation services many years ago. Today, together they have an opportunity to make an impact with remote clinical operations on a much bigger scale.

Advanced analytics is a fast-expanding market and one that continues to accelerate as more and more companies start to buy into the use of greater analytics and AI solutions. Forecasts indicate that the market is set to grow from $33.8 billion in 2021 to $89.8 billion by 2026. That represents a Compound Annual Growth Rate of 21.6%. Some of the factors behind the significant increase in the size of the data analytics market include the increasing use of AI and ML technologies to generate real-time customer insights. The impact of the pandemic has been substantial in terms of driving companies to start using this technology, with the goal of creating more effective strategies to achieve goals such as greater engagement via digital channels, as well as supporting employees through ongoing disruption and managing challenging moments in supply chains. As more organizations reap the benefits of advanced analytics, the global market will continue to grow.

Glass is well established as a popular construction material and looks set to become even more of a magnet for investment going forward. A new report has identified the glass façade market as one set for significant growth over the next six years. According to the latest forecasts, the market is going to reach a value of $92.6 billion by 2026, which represents a Compound Annual Growth Rate expansion of 3.9%. Glass façades have become a first choice in construction due to the qualities that they bring to a build, including energy efficiency, cost-effectiveness and aesthetics. Tempered glass is set to see a particularly impressive rise in growth - this material allows building design to make the best use of natural light and reduce energy consumption so it is on-trend with many of the sustainable initiatives happening right now. This and other factors, such as the rise in raw energy costs, are going to work to drive up the value of the market by 2028.

Regenerative medicine is developing an increasingly visible reputation in healthcare, both among patients and professionals. This innovative sector has enormous potential for changing outcomes for patients thanks to treatments such as cell-tissue therapeutics and products like exosomes and Chimeric antigen receptor T cell therapy. Patients are becoming increasingly aware of, not just the risks that are associated with regenerative medicine, but the advantages too. As a result, forecasts for the increase in the size of the regenerative medicine market are substantial, especially as a wider range of products is increasingly being launched to help prevent complications in patients. One study has found that by 2028 the market for regenerative medicine is likely to be worth $12.9 billion. A particular focus for those operating in regenerative medicine has been the need to spread awareness so that patients can make informed decisions that lead to better outcomes where treatments are concerned.

It's not breaking news to say that the market for cloud infrastructure is still growing at a very impressive rate. Even as the market starts to mature, the likes of Amazon, Google and Microsoft are seeing incredible increases in revenue, especially given the impact of mass remote working over the past year. Google and Microsoft are growing at around 40% a quarter, while Amazon is just under that. Overall, the market has seen a huge increase in just a single year with a spike of $50 billion in business in just 12 months. Despite an overall increase in the market, the big three players have retained a fairly similar market share over the past year. Amazon remains the largest player with a 33% share, while Microsoft has 21% and Google has 10%. This market share isn't forecast to change that much, even though the cloud infrastructure market will continue to grow at a significant pace.

Over the past year, we have begun to see many talented people moving roles to look for new challenges. In 2022, those in jobs such as forensic engineering could find that they have even more to look forward to via a new employer, as these are set to be some of the top 10 paying jobs of the year. This data comes from a January 2022 report that identified how skills shortages in many areas are creating significantly increased demand.

The demand for clinical operations staff has soared during the pandemic and in most locations, this has created some serious skills shortages. As a result, many US hospitals have turned to overseas hires to fill the gaps. One agency recruiting clinical operations staff from overseas to place in US hospitals saw demand surge from just 800 places a year pre-pandemic to 4,000 today.

The same mRNA technology used in Pfizer-BioNTech's and Moderna's Covid vaccines is being trialed as a unique new medical engineering cancer treatment. The way that the vaccines have worked for COVID has been to teach the body to target the virus - now the same approach is being focused on cancer cells too. The company behind the vaccine is BioNTech, which is the German pharmaceutical business that partnered with Pfizer in 2020 to produce the first vaccine that was authorized for use against COVID in the US.

Gene therapy is a vital field and one generating a wealth of R&D jobs in pharma today. Companies such as Pfizer are keen to capitalize on progress, as this represents the next phase of innovation for patients currently living day-to-day with rare diseases. In order to push forward its progress in gene therapy, Pfizer has now announced the opening of a new clinical manufacturing facility in Durham, NC.

A mass movement of workers through the employment world has affected every sector in the past year. Labeled 'The Great Resignation' this shift is making it even more difficult for organizations to fill recruitment requirements. This is a particular problem for fields such as biotech, where there are already skills shortages.

USA construction spending is on the up, not just on a month-to-month basis but also compared to the levels for the previous year. For example, spending in November last year was higher than both October and November 2020 thanks to gains made in key areas such as private residential projects. According to the Associated General Contractors of America, this, combined with private non-residential projects, was enough to outweigh many of the slowdowns in public sector spending.

The past two years saw a rapid increase in the pace of tech adoption across many sectors, with large numbers of organizations adapting strategies to keep up with change imposed by the pandemic. This created something of a seismic shift in the skills market, especially with respect to upskilling and reskilling to help cope with an increase in tech integration. In 2022, the demand for data analytics skills is forecast to increase significantly, as this initial wave of upgrading goes to another level.

The deployment of the cloud in the healthcare sector has been a key driver in infrastructure market growth. That's according to new research that estimates the healthcare cloud computing market will reach $70 billion by 2028. In 2020, the market was worth $28.5 billion so the figures show a significant shift.

Investment in gene therapy is going to be positive in 2022, according to industry insiders. With estimates revealing that one family a day is now being treated with gene therapy there is clear motivation among investors to help extend the reach of gene therapy in the coming 12 months. There is so much potential in gene therapy - for example, AAV-mediated gene therapies open up the option for a one-off administration that could tackle the underlying disease and make permanent changes to the way that patients receive critical medicine.

Technology is vital to optimizing the process of clinical operations trials in the near future - and this has been brought one step closer by the news that Pfizer and Amazon Web Services are now working together to make this happen. The collaboration is designed to create innovative, cloud-based solutions that will improve how medicines are designed and delivered for clinical trials, as well as how they are distributed for testing in clinical trials.

The need to find ways to tackle the COVID-19 pandemic has created significant global vaccine demand that is driving the pharmaceutical R&D industry towards a forecast of $813 billion by 2026. This is almost double the figures for 2020 and 2021 and represents a spike that even the most positive of outlooks could not have predicted. It has created a whole new swathe of R&D jobs in pharma and opportunities for those looking to take bold steps in this career. There is no doubt that one of the driving forces behind the substantial value increase is the global vaccine demand but there has also been a spike in pharmaceutical R&D spending.

Despite the challenges that every organization has faced due to the pandemic, biomedical engineering is an industry that is experiencing a significant boom. This sector brings together medical and engineering potential, creating devices and tech-driven solutions that are often life-changing for those they benefit. Roles such as biomedical materials engineer - which requires a thorough understanding of materials science and material modeling - and algorithm designer (focused on integrating data from various platforms, such as microfluidic devices) are in increasing demand.

Finding opportunities to ensure that workplace accidents don't get repeated is one of the most important elements in the evolution of the construction sector. Any tool that could be useful to make that happen is worth integrating - and there are plenty on offer now thanks to the way that technology has developed. Job site safety is a high priority for engineering and infrastructure projects and the use of autonomous work vehicles could now make this much easier to achieve.

Construction has suffered like many other industries thanks to the events of the past year or so but this Fall there have been many positive signs. In October, for example, total construction starts increased by 16%. Following a slowdown in the third quarter of this year due to the ongoing issues arising from the pandemic, the figures in October could indicate the beginning of a long-term improvement in construction prospects. A significant rise in the number of non-residential construction projects is having a big impact on the future health of the sector - and the recent infrastructure bill has also been flagged as a potential growth factor.

Pediatric patients in need of a valve replacement have historically had few options. There are two solutions that have traditionally been put forward - a purely mechanical valve, which comes with an increased risk of blood clots, and a valve that has been made from animal tissues (a bioprosthetic valve). The major issue that most children have faced with both of these options is outgrowing them.

Severe spinal cord injuries can be some of the hardest to treat and offer the most difficult path to recovery. Now, the discovery of 'dancing molecules' may provide hope to those who have suffered a devastating spinal cord injury, as they may be able to reverse paralysis and repair tissues. In a new study, paralyzed mice were injected with just one dose of a new therapy - and a month later regained the ability to walk. The treatment sends bioactive signals to trigger cells to repair and regenerate.

The cloud is driving digital transformation across many different sectors today. Organizations eager to move to the next level are focused on finding the right people to help recruit for a more resilient approach, especially given the challenges of recent times. Average salaries for cloud infrastructure jobs are already in the six figures and that's not the only benefit for those who work in this field.

Even in 2021, data science is still a relatively new and growing field in which to work. However, it's also one of the most innovative areas of technology and one where there is huge opportunity for progress. Such has been the demand for those with data analytics skills that data scientist was the number one job in America between 2016 and 2020. Now that organizations are relying even more on data-driven decision making there is a huge market for data analytics jobs and those with the right skill set to help businesses start using the data they have to thrive.

Finding new ways to treat inherited diseases has been a key priority for the biomedical sector. Now, Chroma Medicine, which is a new start-up with an impressive $125 million in funding plans to use gene editing in order to develop treatments that are designed to alter the epigenome.

Clinical trial management has faced many obstacles in recent times, not least thanks to the COVID-19 pandemic. However, technology has the potential to help transform this vital field of life sciences and to create opportunities to do more with the insights and research available. AI-powered support automation - chatbots - for example, can provide a lot of key support for clinical study, especially when it comes to organizing the more mundane parts of the process.